The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse
Open accessAbstract
Background: Defects in the small intestinal epithelial barrier have been associated with inflammatory bowel disease but their role in the causation of disease is still a matter of debate. In some models of disease increased permeability appears to be a very early event. The interleukin 10 (IL10) gene-deficient mouse spontaneously develops colitis after 12 weeks of age. These mice have been shown to have increased small intestinal permeability that appears early in life. Furthermore, the development of colitis is dependent upon luminal agents, as animals do not develop disease if raised under germ-free conditions. Aims: To determine if the elevated small bowel permeability can be prevented, and if by doing so colonic disease is prevented or attenuated. Methods: IL10 gene-deficient (IL10−/−) mice) were treated with AT-1001 (a zonulin peptide inhibitor), a small peptide previously demonstrated to reduce small intestinal permeability. Small intestinal permeability was measured, in vivo, weekly from 4 to 17 weeks of age. Colonic disease was assessed at 8 weeks in Ussing chambers, and at 17 weeks of age inflammatory cytokines and myeloperoxidase were measured in the colon. Colonic permeability and histology were also endpoints. Results: Treated animals showed a marked reduction in small intestinal permeability. Average area under the lactulose/mannitol time curve: 5.36 (SE 0.08) in controls vs 3.97 (SE 0.07) in the high-dose AT-1001 group, p<0.05. At 8 weeks of age there was a significant reduction of colonic mucosal permeability and increased electrical resistance. By 17 weeks of age, secretion of tumour necrosis factor α (TNFα) from a colonic explant was significantly lower in the treated group (25.33 (SE 4.30) pg/mg vs 106.93 (SE 17.51) pg/ml in controls, p<0.01). All other markers also demonstrated a clear reduction of colitis in the treated animals. Additional experiments were performed which demonstrated that AT-1001 was functionally active only in the small intestine. Conclusions: This work suggests that increased intestinal permeability may be an important aetiological event in the development of colitis in IL10−/− mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., & De Simone, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,102
Self-citationProinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms
Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C. A., Madara, J. L., Hopkins, A. M., & Nusrat, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6164 · Cited by 902
HOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760
Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02169-3 · Cited by 670
Alterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634
Self-citationSapone, A., de Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F., Lampis, R., Kryszak, D., Cartenì, M., Generoso, M., et al. (2006) · Diabetes · doi:10.2337/db05-1593 · Cited by 543
Human zonulin, a potential modulator of intestinal tight junctions
Wang, W., Uzzau, S., Goldblum, S. E., & Fasano, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4435 · Cited by 470
Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., & Goldblum, S. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118114 · Cited by 342
Madsen, K. L., Malfair, D., Gray, D., Doyle, J. S., Jewell, L. D., & Fedorak, R. N. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00004 · Cited by 318
Self-citationWatts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not, T., Zielke, R., & Fasano, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500178102 · Cited by 313
Intestinal permeability in patients with Crohn's disease and their healthy relatives
Katz, K. D., Hollander, D., Vadheim, C. M., McElree, C., Delahunty, T., Dadufalza, V. D., Krugliak, P., & Rotter, J. I. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91499-6 · Cited by 302
Söderholm, J. D., Olaison, G., Peterson, K. H., Franzén, L. E., Lindmark, T., Wirén, M., Tagesson, C., & Sjödahl, R. (2002) · Gut · doi:10.1136/gut.50.3.307 · Cited by 289
Saverymuttu, S. H., Camilleri, M., Rees, H., Lavender, J. P., Hodgson, H. J. F., & Chadwick, V. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90376-8 · Cited by 274
Munkholm, P., Langholz, E., Hollander, D., Thornberg, K., Orholm, M., Katz, K. D., & Binder, V (1994) · Gut · doi:10.1136/gut.35.1.68 · Cited by 225
Discrimination of site-specific alterations in gastrointestinal permeability in the rat
Meddings, J. B., & Gibbons, I. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70636-5 · Cited by 192
Self-citationIncreased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat
Meddings, J. B., Jarand, J., Urbanski, S. J., Hardin, J., & Gall, D. G. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.4.g951 · Cited by 185
Self-citationFasano, A., Uzzau, S., Fiore, C., & Margaretten, K. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041245 · Cited by 172
The primary defect in experimental ileitis originates from a nonhematopoietic source
Olson, T. S., Reuter, B. K., Scott, K. G.-E., Morris, M. A., Wang, X.-M., Hancock, L. N., Burcin, T. L., Cohn, S. M., Ernst, P. B., Cominelli, F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050407 · Cited by 172
Self-citationResta‐Lenert, S. C., Smitham, J. E., & Barrett, K. E. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2004 · Cited by 146
Atisook, K., Carlson, S., & Madara, J. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.1.c77 · Cited by 141
Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins
Fasano, A., & Nataro, J. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.045 · Cited by 123
Rodriguez, P., Heyman, M., Candalh, C., Blaton, M. A., & Bouchaud, C. (1995) · Cytokine · doi:10.1006/cyto.1995.0060 · Cited by 105
Measurement of short-circuit current and ion transport across the ileum
Clarkson, T. W., & Toole, S. R. (1964) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1964.206.3.658 · Cited by 99
Permeability, zonulin production, and enteropathy in dermatitis herpetiformis
Smecuol, E., Sugai, E., Niveloni, S. I., Vázquez, H., Pedreira, S. C., Mazure, R. M., Moreno, M. L., Label, M. G., Mauriño, E. C., Fasano, A., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00778-5 · Cited by 87
Self-citationSerosal But Not Mucosal Endotoxin Exposure Increases Intestinal Permeability in Vitro in the Rat
Osman, N., WESTRÖM, B. R., & KARLSSO, B. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850172520 · Cited by 33
Sodium-glucose cotransport and epithelial permeability
Madara, J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90099-x · Cited by 28
Intestinal permeability in patients with Crohn's disease.
Meddings, J. B., Sutherland, L. R., & May, G. R. (1994) · Gut · doi:10.1136/gut.35.11.1675-b · Cited by 24
Self-citation
Cited by
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
“Another recent study showed that a peptide capable of enhancing small-intestinal barrier function reduced the extent of mucosal inflammation in IL-10-deficient mic”
BackgroundIntestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Metadata
- Authors
- Arrieta, M. C., Madsen, K., Doyle, J., & Meddings, J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-10-01
- Volume
- 58
- Issue
- 1
- Pages
- 41-48
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2146367607
- Cited by
- 323
- References
- 29
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.